The potential of remdesivir to affect function, metabolism and proliferation of cardiac and kidney cells in vitro

Remdesivir is a prodrug of a nucleoside analog and the first antiviral therapeutic approved for coronavirus disease. Recent cardiac safety concerns and reports on remdesivir-related acute kidney injury call for a better characterization of remdesivir toxicity and understanding of the underlying mech...

Descripción completa

Detalles Bibliográficos
Autores principales: Merches, Katja, Breunig, Leonie, Fender, Julia, Brand, Theresa, Bätz, Vanessa, Idel, Svenja, Kollipara, Laxmikanth, Reinders, Yvonne, Sickmann, Albert, Mally, Angela, Lorenz, Kristina
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2022
Materias:
Organ Toxicity and Mechanisms
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110936/
https://www.ncbi.nlm.nih.gov/pubmed/35579693
http://dx.doi.org/10.1007/s00204-022-03306-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9110936/
https://www.ncbi.nlm.nih.gov/pubmed/35579693
http://dx.doi.org/10.1007/s00204-022-03306-1

Ejemplares similares